Abstract
Ovarian cancer is the fourth-most-common cause of death among all malignant cancers in women in Poland. This study aimed to compare the functioning of the urinary system and quality of life in women in the 12-month period following the completion of surgery or adjuvant treatment for ovarian cancer, with patients who underwent a hysterectomy for non-oncological reasons (control group). The study group consisted of 50 patients diagnosed with stage I–III ovarian cancer. Among 38 patients with type II ovarian cancer (group A), surgery followed by first-line chemotherapy was performed. Within this group of patients, 20 had stage I ovarian cancer, while 18 had stage II ovarian cancer. The study was performed at least 6 months after the final chemotherapy cycle, with no clinical, marker or radiological recurrence determined. On the other hand, in 12 patients with stage I type I ovarian cancer, oncological treatment consisted of only surgery, without the need for adjuvant chemotherapy, due to the low stage of the lesions (group B). In turn, the control group consisted of 50 women who underwent uterine removal for non-oncological reasons (group C). The assessment of quality of life was conducted using the questionnaires: Satisfaction with Life Scale (SWLS); Incontinence Impact Questionnaire, short form (IIQ-7); Urogenital Distress Inventory (UDI-6); and the Sexual Satisfaction Scale for 3, 6, 9, and 12 months after the conclusion of oncological treatment. During the follow-up, a significant reduction in the quality of everyday life and sexual life was noted among patients with ovarian cancer, more pronounced in group B, compared to the control group (p < 0.05). The risk of urinary incontinence is independent of the treatment regimen chosen for ovarian cancer. It is necessary to consider comprehensive psychological care and sexual therapy in patients with ovarian cancer and their families.
Highlights
According to the National Cancer Registry (NCR), in 2020, ovarian cancer morbidity in Poland was the second-highest as to the frequency of occurrence among cancers of the reproductive organs—3864 cases, after endometrial cancer, with 6659 cases
The aim of this study is to compare the functioning of the urinary system in women and their quality of life in the 12-month period after the end of surgery or adjuvant treatment for ovarian cancer, with patients after the removal of the uterus with appendages for non-oncological reasons
Urinary system dysfunction negatively influences the quality of life of the patients of both study groups compared to the control group
Summary
According to the National Cancer Registry (NCR), in 2020, ovarian cancer morbidity in Poland was the second-highest as to the frequency of occurrence among cancers of the reproductive organs—3864 cases, after endometrial cancer, with 6659 cases It constitutes the fourth-most-common cause of death among all malignant cancers in women in Poland [1]. 30% of all ovarian cancer cases, developing based on benign ovarian tumors or borderline malignancy cancers It grows in the form of a clear tumor in the ovary, and after some time, it spreads to the peritoneal cavity. It is usually endometrial or mucinous, having a slightly better prognosis than type II.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
